Wei Luo

Dr. Wei Luo


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JCJin-Huan Cui
Jin-Huan Cui
KLKai-Rong Lin
Kai-Rong Lin
SYSong-Hua Yuan
Song-Hua Yuan
YJYa-Bin Jin
Ya-Bin Jin
XCXiang-Ping Chen
Xiang-Ping Chen
WLWei Luo
Wei Luo
There is increasing evidence that deep sequencing-based T cell repertoire can sever as a biomarker of immune response in cancer patients; however, the characteristics of T cell repertoire including diversity and similarity, as well as its prognostic significance in patients with cervical cancer (CC) remain unknown. In this study, we applied a high throughput T cell receptor (TCR) sequencing method to characterize the T cell repertoires of peripheral blood samples from 25 CC patients, 30 cervical intraepithelial neoplasia (CIN) patients and 20 healthy women for understanding the immune alterations during the cervix carcinogenesis. In addition, we also explored the signatures of TCR repertoires in the cervical tumor tissues and paired sentinel lymph nodes from 16 CC patients and their potential value in predicting the prognosis of patients. Our results revealed that the diversity of circulating TCR repertoire gradually decreased during the cervix carcinogenesis and progression, but the circulating TCR repertoires in CC patients were more similar to CIN patients than healthy women. Interestingly, several clonotypes uniquely detected in CC patients tended to share similar CDR3 motifs, which differed from those observed in CIN patients. In addition, the TCR repertoire diversity in sentinel lymphatic nodes from CC patients was higher than in tumor tissues. More importantly, less clonotypes in TCR repertoire of sentinel lymphatic node was associated with the poor prognosis of the patients. Overall, our findings suggested that TCR repertoire might be a potential indicator of immune monitoring and a biomarker for predicting the prognosis of CC patients. Although functional studies of T cell populations are clearly required, this study have expanded our understanding of T cell immunity during the development of CC and provided an experimental basis for further studies on its pathogenesis and immunotherapy.

4 October 2022 in Frontiers in Surgery
Verified
Journal Article
Open access
COChubin Ou
Chubin Ou
SZSitong Zhou
Sitong Zhou
RYRonghua Yang
Ronghua Yang
WJWeili Jiang
Weili Jiang
HHHaoyang He
Haoyang He
JLJiehua Li
Jiehua Li
Introduction: Skin cancer is one of the most common types of cancer. An accessible tool to the public can help screening for malign lesion. We aimed to develop a deep learning model to classify skin lesion using clinical images and meta information collected from smartphones.Methods: A deep neural network was developed with two encoders for extracting information from image data and metadata. A multimodal fusion module with intra-modality self-attention and inter-modality cross-attention was proposed to effectively combine image features and meta features. The model was trained on tested on a public dataset and compared with other state-of-the-art methods using five-fold cross-validation.Results: Including metadata is shown to significantly improve a model's performance. Our model outperformed other metadata fusion methods in terms of accuracy, balanced accuracy and area under the receiver-operating characteristic curve, with an averaged value of 0.768±0.022, 0.775±0.022 and 0.947±0.007.Conclusion: A deep learning model using smartphone collected images and metadata for skin lesion diagnosis was successfully developed. The proposed model showed promising performance and could be a potential tool for skin cancer screening.

17 October 2022 in Viruses
Verified
Journal Article
Open access
PDF file
YGYang Ge
Yang Ge
PWPin Wan
Pin Wan
YZYaru Zhang
Yaru Zhang
QTQiaoru Tan
Qiaoru Tan
MQMuhammad Suhaib Qudus
Muhammad Suhaib Qudus
JWjianguo Wu
jianguo Wu
Hepatitis B virus (HBV) infection is still one of the most dangerous viral illnesses. HBV infects around 257 million individuals worldwide. Hepatitis B in many individuals ultimately develops hepatocellular carcinoma (HCC), which is the sixth most common cancer and the third leading cause of cancer-related deaths worldwide. The innate immunity acts as the first line of defense against HBV infection through activating antiviral genes. Along with the immune responses, pro-inflammatory cytokines are triggered to enhance the antiviral responses, but this may result in acute or chronic liver inflammation, especially when the clearance of virus is unsuccessful. To a degree, the host innate immune and inflammatory responses dominate the HBV infection and liver pathogenesis. Thus, it is crucial to figure out the signaling pathways involved in the activation of antiviral factors and inflammatory cytokines. Here, we review the interplay between HBV and the signal pathways that mediates innate immune responses and inflammation. In addition, we summarize current therapeutic strategies for HBV infection via modulating innate immunity or inflammation. Characterizing the mechanisms that underlie these HBV-host interplays might provide new approaches for the cure of chronic HBV infection.

28 August 2018 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
YJYa-Bin Jin
Ya-Bin Jin
WLWei Luo
Wei Luo
GZGuo-Yi Zhang
Guo-Yi Zhang
KLKai-Rong Lin
Kai-Rong Lin
JCJin-Huan Cui
Jin-Huan Cui
YWYue-Jian Wang
Yue-Jian Wang

9 August 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
JHJiaqi Hu
Jiaqi Hu
CHChongyin Han
Chongyin Han
JZJiayuan Zhong
Jiayuan Zhong
HLHuisheng Liu
Huisheng Liu
RLRui Liu
Rui Liu
FLFei Ling
Fei Ling
Immunotherapy has achieved positive clinical responses in various cancers. However, in advanced colorectal cancer (CRC), immunotherapy is challenging because of the deterioration of T-cell exhaustion, the mechanism of which is still unclear. In this study, we depicted CD8+ T-cell developmental trajectories and characterized the pre-exhausted T cells isolated from CRC patients in the scRNA-seq data set using a dynamic network biomarker (DNB). Moreover, CCT6A identified by DNB was a biomarker for pre-exhausted T-cell subpopulation in CRC. Besides, TUBA1B expression was triggered by CCT6A as DNB core genes contributing to CD8+ T cell exhaustion, indicating that core genes serve as biomarkers in pre-exhausted T cells. Remarkably, both TUBA1B and CCT6A expressions were significantly associated with the overall survival of COAD patients in the TCGA database (p = 0.0082 and p = 0.026, respectively). We also observed that cellular communication between terminally differentiated exhausted T cells and pre-exhausted T cells contributes to exhaustion. These findings provide new insights into the mechanism of T-cell exhaustion and provide clue for targeted immunotherapy in CRC.

3 September 2022 in Biomaterials
Verified
Journal Article
Closed access
YNYichu Nie
Yichu Nie
WZWeilang Zhang
Weilang Zhang
WXWenqing Xiao
Wenqing Xiao
WZWeiwei Zeng
Weiwei Zeng
TCTing Chen
Ting Chen
XJXiaoyuan Ji
Xiaoyuan Ji